scholarly journals Activation of PPARγ by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia

Blood ◽  
2017 ◽  
Vol 129 (13) ◽  
pp. 1802-1810 ◽  
Author(s):  
Emily R. Finch ◽  
Diwakar B. Tukaramrao ◽  
Laura L. Goodfield ◽  
Michael D. Quickel ◽  
Robert F. Paulson ◽  
...  

Key Points Endogenous CyPG PGJ2 targets LSCs through PPARγ activation. Selenium supplementation could serve as an adjunct therapy for CML.

Blood ◽  
2013 ◽  
Vol 121 (18) ◽  
pp. 3759-3767 ◽  
Author(s):  
Johnnie J. Orozco ◽  
Tom Bäck ◽  
Aimee Kenoyer ◽  
Ethan R. Balkin ◽  
Donald K. Hamlin ◽  
...  

Key Points Astatination of anti-CD45 antibody via a closo-decaborate compound yields a stable conjugate that targets radiation to hematologic organs. 211At-anti-CD45 radioimmunotherapy combined with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.


Blood ◽  
2018 ◽  
Vol 131 (15) ◽  
pp. 1730-1742 ◽  
Author(s):  
Monica Cusan ◽  
Sheng F. Cai ◽  
Helai P. Mohammad ◽  
Andrei Krivtsov ◽  
Alan Chramiec ◽  
...  

Key Points LSD1 inhibition induces a global increase in chromatin accessibility, whereas DOT1L inhibition induces global decreases in accessibility. Perturbation of PU.1 and C/EBPα expression renders AML cells more resistant to LSD1 inhibition.


Blood ◽  
2017 ◽  
Vol 130 (22) ◽  
pp. 2410-2419 ◽  
Author(s):  
Shannon K. Oda ◽  
Andrew W. Daman ◽  
Nicolas M. Garcia ◽  
Felecia Wagener ◽  
Thomas M. Schmitt ◽  
...  

Key Points IFPs can convert signals from inhibitory ligands into activating signals. Costimulation was most effectively achieved by engineering the IFP to promote the ability to localize in the immunological synapse.


Blood ◽  
2016 ◽  
Vol 127 (3) ◽  
pp. 352-359 ◽  
Author(s):  
Johnnie J. Orozco ◽  
Aimee Kenoyer ◽  
Ethan R. Balkin ◽  
Ted A. Gooley ◽  
Donald K. Hamlin ◽  
...  
Keyword(s):  

Key Points Anti-CD45 RIT may replace TBI and simplify BMT-preparative regimens. Anti-CD45 RIT and haploidentical BMT, without TBI, prolongs survival in a murine leukemia model.


2015 ◽  
pp. 1649 ◽  
Author(s):  
Heshu Sulaiman Rahman ◽  
Abdullah Rasedee ◽  
Zeenathul Nazariah Binti Allaudin ◽  
Max Chartrand ◽  
Swee Keong Yeap ◽  
...  

Author(s):  
L. Z. de Tkaczevski ◽  
E. de Harven ◽  
C. Friend

Despite extensive studies, the correlation between the morphology and pathogenicity of murine leukemia viruses (MLV) has not yet been clarified. The virus particles found in the plasma of leukemic mice belong to 2 distinct groups, 1 or 2% of them being enveloped A particles and the vast majority being of type C. It is generally believed that these 2 types of particles represent different phases in the development of the same virus. Particles of type A have been thought to be an earlier form of type C particles. One of the tissue culture lines established from Friend leukemia solid tumors has provided the material for the present study. The supernatant fluid of the line designated C-1A contains an almost pure population of A particles as illustrated in Figure 1. The ratio is, therefore, the reverse of what is unvariably observed in the plasma of leukemic mice where C particles predominate.


Author(s):  
Ray A. Weigand ◽  
Gregory C. Varjabedian

We previously described the intracellular localization of murine mammary tumor virus (MuMTV) p28 protein in thin sections (1). In that study, MuMTV containing cells fixed in 3% paraformaldehyde plus 0.05% glutaraldehyde were labelled after thin sectioning using ferritin-antiferritin in an unlabelled antibody technique. We now describe the labelling of murine leukemia virus (MuLV) particles using the unlabelled antibody technique coupled to ferritin-Fab antiferritin. Cultures of R-MuLV in NIH/3T3 cells were grown to 90% confluence (2), fixed with 2% paraformaldehyde plus 0.5% glutaraldehyde in 0.1 M cacodylate at pH 7.2, postfixed with buffered 17 OsO4, dehydrated with a series of etha-nols, and embedded in Epon. Thin sections were collected on nickel grids, incubated in 107 H2O2, rinsed in HEPES buffered saline, and subjected to the immunoferritin labelling procedure. The procedure included preincubation in 27 egg albumin, a four hour incubation in goat antisera against purified gp69/71 of MuLV (3) (primary antibody), incubation in F(ab’)2 fragments of rabbit antisera to goat IgG (secondary antibody), incubation in apoferritin, incubation in ferritin-Fab ferritin, and a brief fixation with 2% glutaraldehyde. The sections were stained with uranyl acetate and examined in a Siemens IA electron microscope at an accelerating voltage of 60 KV.


Author(s):  
Laura S. DeThorne ◽  
Kelly Searsmith

Purpose The purpose of this article is to address some common concerns associated with the neurodiversity paradigm and to offer related implications for service provision to school-age autistic students. In particular, we highlight the need to (a) view first-person autistic perspectives as an integral component of evidence-based practice, (b) use the individualized education plan as a means to actively address environmental contributions to communicative competence, and (c) center intervention around respect for autistic sociality and self-expression. We support these points with cross-disciplinary scholarship and writings from autistic individuals. Conclusions We recognize that school-based speech-language pathologists are bound by institutional constraints, such as eligibility determination and Individualized Education Program processes that are not inherently consistent with the neurodiversity paradigm. Consequently, we offer examples for implementing the neurodiversity paradigm while working within these existing structures. In sum, this article addresses key points of tension related to the neurodiversity paradigm in a way that we hope will directly translate into improved service provision for autistic students. Supplemental Material https://doi.org/10.23641/asha.13345727


Sign in / Sign up

Export Citation Format

Share Document